Malignant tumours after renal transplantation

Scand J Urol Nephrol. 1996 Oct;30(5):357-62. doi: 10.3109/00365599609181310.

Abstract

In 1243 patients after renal transplantation, 39 malignant tumours were detected in 37 patients. The average latency period between transplantation and tumour disease was 72 months. Tumours included 8 malignant lymphomas, 7 dermatomas and 24 visceral tumours. The patients who developed a tumour had received fewer blood transfusions before transplantation than a tumour-free control group of 60 patients with renal transplants. Rejection crises occurred in a significantly smaller number of tumour patients compared with the control group.

Publication types

  • Review

MeSH terms

  • Azathioprine / administration & dosage
  • Cyclosporine / administration & dosage
  • Female
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Kidney Transplantation / adverse effects*
  • Lymphoma, Non-Hodgkin / etiology*
  • Male
  • Methylprednisolone / administration & dosage
  • Postoperative Complications
  • Prednisolone / administration & dosage
  • Risk

Substances

  • Immunosuppressive Agents
  • Cyclosporine
  • Prednisolone
  • Azathioprine
  • Methylprednisolone